Impact of metabolic syndrome on global left ventricular function: As evaluated by the myocardial performance index

Journal of the Saudi Heart Association

Volumn 26, Issue 3, 2014, Pages 145-151

  Sreenivasa Kumar, M L ^a   Rajasekhar, D ^a   Vanajakshamma, V ^a   Latheef, K ^a  

^a SRI VENKATESWARA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Isovolumic contraction time; Isovolumic relaxation time; Metabolic syndrome; Myocardial performance index

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AORTA VALVE; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; HEART INDEX; HEART LEFT VENTRICLE EJECTION TIME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PERFORMANCE; HEART MUSCLE RELAXATION; HEART VENTRICLE EJECTION TIME; HUMAN; HYPERTRIGLYCERIDEMIA; LEFT VENTRICULAR MYOCARDIAL PERFORMANCE INDEX; MALE; METABOLIC SYNDROME X; MITRAL VALVE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE WAVE; TISSUE DOPPLER IMAGING; TRANSTHORACIC ECHOCARDIOGRAPHY; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84902543314     PISSN: 10167315     EISSN: 22125043     Source Type: Journal    
DOI: 10.1016/j.jsha.2014.03.003     Document Type: Article

References (26)

1. Isomaa B., Almgren P., Tuomi T., Forsén B., Lahti K., Nissen M., et al. Cardiovascular morbidity and mortality associated with metabolic syndrome. Diabetes Care 2001, 24(4):683-689.
2. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288(21):2709-2716.
3. Olijhoek J.K., van der Graaf Y., Banga J.D., Algra A., Rabelink T.J., Visseren F.L., et al. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 2004, 25(4):342-348.
4. Tei C. New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol 1995, 26(2):135-136.
5. Tei C., Ling L.H., Hodge D.O., Bailey K.R., Oh J.K., Rodeheffer R.J., et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function - a study in normals and dilated cardiomyopathy. J Cardiol 1995, 26(6):357-366.
6. Alberti K.G., Zimmet P., Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005, 366(9491):1059-1062.
7. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989, 2(5):358-367.
8. Quiñones M.A., Otto C.M., Stoddard M., Waggoner A., Zoghbi W.A. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002, 15(2):167-184.
9. Armstrong WF, Ryan T, Feigenbaum H. Feigenbaum's Echocardiography. 7th ed. Philadelphia, Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010;143-4.
10. Tekten T., Onbasili A.O., Ceyhan C., Unal S., Discigil B. Novel approach to measure myocardial performance index: pulsed-wave tissue Doppler echocardiography. Echocardiography 2003, 20(6):503-510.
11. Turhan H., Yasar A.S., Yagmur J., Kurtoglu E., Yetkin E. The impact of metabolic syndrome on left ventricular function: evaluated by using the index of myocardial performance. Int J Cardiol 2009, 132(3):382-386.
12. Dayi S.U., Kasikcioglu H., Uslu N., Tartan Z., Uyarel H., Terzi S., et al. Influence of weight loss on myocardial performance index. Heart Vessels 2006, 21(2):84-88.
13. Misra A., Chowbey P., Makkar B.M., Vikram N.K., Wasir J.S., Chadha D., et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India 2009, 57:163-170.
14. Després J.P., Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006, 444(7121):881-887.
15. Voulgari C., Moyssakis I., Papazafiropoulou A., Perrea D., Kyriaki D., Katsilambros N., et al. The impact of metabolic syndrome on left ventricular myocardial performance. Diabetes Metab Res Rev 2010, 26(2):121-127.
16. Bella J.N., Devereux R.B., Roman M.J., Palmieri V., Liu J.E., Paranicas M., et al. Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study). Am J Cardiol 2001, 87(11):1260-1265.
17. Bruch C., Schmermund A., Marin D., Katz M., Bartel T., Schaar J., et al. Tei-index in patients with mild-to-moderate heart failure. Eur Heart J 2000, 21(22):1888-1895.
18. Amlöv J., Lind L., Andrén B., Risérus U., Berglund L., Lithell H. A Doppler-derived index of combined left ventricular systolic and diastolic function is an independent predictor of cardiovascular mortality in elderly men. Am Heart J 2005, 149(5):902-907.
19. Witteles R.M., Fowler M.B. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol 2008, 51(2):93-102.
20. Chinali M., Devereux R.B., Howard B.V., Roman M.J., Bella J.N., Liu J.E., et al. Comparison of cardiac structure and function in American Indians with and without metabolic syndrome (the Strong Heart Study). Am J Cardiol 2004, 93(1):40-44.
21. Wong C.Y., O'Moore-Sullivan T., Fang Z.Y., Haluska B., Leano R., Marwick T.H. Myocardial and vascular dysfunction and exercise capacity in the metabolic syndrome. Am J Cardiol 2005, 96(12):1686-1691.
22. Dutta K., Podolin D.A., Davidson M.B., Davidoff A.J. Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance. Diabetes 2001, 50(5):1186-1192.
23. Rutter M.K., Parise H., Benjamin E.J., Levy D., Larson M.G., Meigs J.B., et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 2003, 107(3):448-454.
24. Tei C., Nishimura R.A., Seward J.B., Tajik A.J. Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr 1997, 10(2):169-178.
25. Wright J.T., Harris-Haywood S., Pressel S., Barzilay J., Baimbridge C., Bareis C.J., et al. Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 2008, 168(2):207-217.
26. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25(6):1105-1187.